Anika Therapeutics, Inc. Cash Flow Statement
ANIK|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
$11M
FY2025
Free Cash Flow
$4M
FY2025
Capital Expenditures
$7M
Cash used for long-term assets
Dividends Paid
N/A
FY2025
Anika Therapeutics, Inc. generated $11M in operating cash flow and $4M in free cash flow in FY2025. Free cash flow margin was 3.9% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$10.9M | -$56.4M | -$82.7M | -$24.0M | $27.2M | $18.7M | $31.8M | $32.5M | $30.8M | $38.3M | $20.6M | $11.8M | $8.5M | $4.3M | $3.7M |
| Depreciation & Amortization | $5.4M | $6.9M | $6.4M | $6.1M | $5.0M | $5.9M | $4.3M | $3.7M | $3.8M | $4.7M | $4.8M | $4.5M | $4.0M | $3.3M | $1.3M |
| Operating Cash Flow | $11.2M | $5.4M | -$1.8M | $13.1M | $37.0M | $34.9M | $40.8M | $24.4M | $39.9M | $40.0M | $25.2M | $10.5M | $10.2M | $7.9M | $3.1M |
| Capital Expenditures | $6.8M | $7.7M | $5.4M | $1.6M | $2.8M | $4.7M | $9.0M | $14.0M | $9.2M | $1.6M | $441.0K | $1.5M | $1.4M | $2.8M | $4.0M |
| Free Cash Flow | $4.4M | -$2.3M | -$7.2M | $11.4M | $34.2M | $30.3M | $31.8M | $10.4M | $30.7M | $38.4M | $24.7M | $9.0M | $8.8M | $5.1M | -$867.5K |
| Share Buybacks | $9.5M | $10.9M | $5.0M | - | $30.0M | $30.0M | $30.0M | $25.0M | $25.0M | $25.0M | - | - | - | - | - |
| FCF Margin | 3.9% | -1.9% | -6.0% | 8.8% | 29.8% | 28.7% | 28.1% | 10.1% | 33.0% | 36.4% | 32.9% | 12.7% | 13.5% | 9.1% | -2.2% |